Four Companies to Know in Hungary
The pharmaceutical industry is one of the pillars of the Hungarian economy and has been identified as a key growth driver for the future by the government of Prime Minister…
Address: Zolyomi ut 23 H-1118 Budapest,Hungary
Tel: +36 1 391 4455
Abiomics Europe Ltd.
„Advanced Biostatistics and Intelligence for the Omics”
Abiomics Europe Ltd. is a technology startup company that was founded in 2009 by bioinformatics and biomedical researchers along with investors. The cooperation between the Semmelweis University, Department of Genetics, Cell- and Immunobiology and the Budapest University of Technology and Economics, Department of Measurement and Information Systems started in 2005 and led to the establishment of the company.
The 5 years of cooperation and joint projects made it clear that modern life science research and development is not possible anymore without advanced information technology support. The GenaGrid consortium was founded in 2008 with the support of the National Office for Research and Technology when new academic and industry partners joined the research group and aims to develop various bioinformatics services. Abiomics Europe Ltd. is the company responsible for the utilization for the intellectual properties of the consortium and has all the exclusive rights for the developed technologies. Abiomics Europe drives the business development, market research and marketing activities for the consortium.
The GenaGrid research group and Abiomics Europe employs almost 30 informaticians and biomedical researchers. The group engages the technologies and software in Asthma and ALL research. The GenaGrid research group operates a genomics lab and the most powerful grid supercomputer dedicated for life science research in Hungary with 512 CPUs (March 2010).
Abiomics provides to their customers advanced information technology support.
The pharmaceutical industry is one of the pillars of the Hungarian economy and has been identified as a key growth driver for the future by the government of Prime Minister…
Dr. Zsuzsanna Fürst, President of the Ethics Committee for Clinical Pharmacology, elaborates on the role and activities of the ethics committee, shares her insights on structural framework of the application…
Dr Beata Sperlagh, Deputy Director of the Institute of Experimental Medicine (IEM), shares her insights on the institute’s involvement in research and with the private sector, the key strengths of…
Irisz Lippai-Nagy, CEO of AmCham Hungary, shares insights on the drivers contributing to economic growth in Hungary, recent policies and reforms, the role of the association, and policy recommendations to…
Oliver Strommer, newly appointed executive director of the British Chamber of Commerce in Hungary (BCCH), introduces the Chamber and its refocused aim of becoming a more dynamic player in business…
Investments in research and development are on the rise in Hungary, backed up by government initiatives, but the country needs a more unified effort between the public and private sectors…
Hungary’s two largest pharma firms, Egis Pharmaceuticals and Gedeon Richter, are stepping up their biosimilars offering; providing the European market with more affordable biologic medicines and bolstering Hungary’s footprint in…
Like many of its European counterparts, Hungary is suffering from medicine shortages. Vaccines, vitamins, and orphan drugs are some of the most affected areas and oncology patients are now also…
Hungarian patients currently experience longer wait times and more limited access to subsidised innovative medicines than their neighbours in Bulgaria and Slovakia.leading some organisations to urge the government to increase…
Hungary’s Minister of Finance Mihály Varga has repeatedly underlined the importance of the pharmaceutical industry to the country’s economy in recent weeks. With this strong governmental backing, pharma stands to…
Hungary has long been one of the leading countries in Central and Eastern Europe for clinical trials. However, a downward trend in the number of research projects being conducted in…
Cancer is on the rise in Hungary and survival rates are considerably lower than the European average. The country’s innovative pharma association has taken the initiative to suggest measures that…
See our Cookie Privacy Policy Here
